A citation-based method for searching scientific literature

Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey, Hannah E Hughes-Parry, Melinda Iliopoulos, Katherine A Watson, Matthias Mulazzani, Kylie Luong, Colleen D'Arcy, Lucy C Sullivan, Ben R Kiefel, Ryan S Cross, Misty R Jenkins. Clin Transl Immunology 2021
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight.
Craig A Land, Phillip R Musich, Dalia Haydar, Giedre Krenciute, Qian Xie. J Transl Med 2020
12
100

TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM.
Alice L Hung, Russell Maxwell, Debebe Theodros, Zineb Belcaid, Dimitrios Mathios, Andrew S Luksik, Eileen Kim, Adela Wu, Yuanxuan Xia, Tomas Garzon-Muvdi,[...]. Oncoimmunology 2018
116
50

Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice.
Salah-Eddine Lamhamedi-Cherradi, Shi-Jun Zheng, Kimberly A Maguschak, Jacques Peschon, Youhai H Chen. Nat Immunol 2003
270
50

Anti-Angiogenics: Current Situation and Future Perspectives.
Katja Zirlik, Justus Duyster. Oncol Res Treat 2018
72
50

Next generation of immune checkpoint therapy in cancer: new developments and challenges.
Julian A Marin-Acevedo, Bhagirathbhai Dholaria, Aixa E Soyano, Keith L Knutson, Saranya Chumsri, Yanyan Lou. J Hematol Oncol 2018
312
50

Distribution and functional plasticity of peripheral blood Th(c)17 and Th(c)1 in rheumatoid arthritis.
Ana Henriques, Vera Gomes, Cátia Duarte, Susana Pedreiro, Tiago Carvalheiro, Marlene Areias, Armando Caseiro, António José Gabriel, Paula Laranjeira, Maria Luísa Pais,[...]. Rheumatol Int 2013
11
50

Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.
Ludmila Prokunina, Leonid Padyukov, Anna Bennet, Ulf de Faire, Björn Wiman, Jonathan Prince, Lars Alfredsson, Lars Klareskog, Marta Alarcón-Riquelme. Arthritis Rheum 2004
139
50

TGFbeta in Cancer.
Joan Massagué. Cell 2008
50

Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand.
B Huard, P Gaulard, F Faure, T Hercend, F Triebel. Immunogenetics 1994
120
50


CD226 Gly307Ser association with multiple autoimmune diseases: a meta-analysis.
Zhi-Xin Qiu, Kui Zhang, Xue-Song Qiu, Min Zhou, Wei-Min Li. Hum Immunol 2013
31
50

Role of IL-17 in Glioma Progression.
Prahlad Parajuli, Sandeep Mittal. J Spine Neurosurg 2013
11
50

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis.
Ilona Kryczek, Allen T Bruce, Johann E Gudjonsson, Andrew Johnston, Abhishek Aphale, Linhua Vatan, Wojciech Szeliga, Yin Wang, Yan Liu, Theodore H Welling,[...]. J Immunol 2008
327
50

Lost in translation: animal models and clinical trials in cancer treatment.
Isabella Wy Mak, Nathan Evaniew, Michelle Ghert. Am J Transl Res 2014
503
50

Cutting edge: TIGIT has T cell-intrinsic inhibitory functions.
Nicole Joller, Jason P Hafler, Boel Brynedal, Nasim Kassam, Silvia Spoerl, Steven D Levin, Arlene H Sharpe, Vijay K Kuchroo. J Immunol 2011
270
50

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.
Paul Lesueur, Justine Lequesne, Jean-Michel Grellard, Audrey Dugué, Elodie Coquan, Pierre-Emmanuel Brachet, Julien Geffrelot, William Kao, Evelyne Emery, David Hassanein Berro,[...]. BMC Cancer 2019
38
50

CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial.
V Viglietta, K Bourcier, G J Buckle, B Healy, H L Weiner, D A Hafler, S Egorova, C R G Guttmann, J R Rusche, S J Khoury. Neurology 2008
68
50

Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)
R Nitsch, I Bechmann, R A Deisz, D Haas, T N Lehmann, U Wendling, F Zipp. Lancet 2000
258
50

Identification and characterization of a new member of the TNF family that induces apoptosis.
S R Wiley, K Schooley, P J Smolak, W S Din, C P Huang, J K Nicholl, G R Sutherland, T D Smith, C Rauch, C A Smith. Immunity 1995
50

Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.
Hesham Abboud, John C Probasco, Sarosh Irani, Beau Ances, David R Benavides, Michael Bradshaw, Paulo Pereira Christo, Russell C Dale, Mireya Fernandez-Fournier, Eoin P Flanagan,[...]. J Neurol Neurosurg Psychiatry 2021
8
50

Ex-Th17 (Nonclassical Th1) Cells Are Functionally Distinct from Classical Th1 and Th17 Cells and Are Not Constrained by Regulatory T Cells.
Sharee A Basdeo, Deborah Cluxton, Jamal Sulaimani, Barry Moran, Mary Canavan, Carl Orr, Douglas J Veale, Ursula Fearon, Jean M Fletcher. J Immunol 2017
64
50

Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer.
Yang Song, Jian Ming Yang. Biochem Biophys Res Commun 2017
37
50

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.
J R Abrams, M G Lebwohl, C A Guzzo, B V Jegasothy, M T Goldfarb, B S Goffe, A Menter, N J Lowe, G Krueger, M J Brown,[...]. J Clin Invest 1999
471
50

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma.
Kurt A Schalper, Maria E Rodriguez-Ruiz, Ricardo Diez-Valle, Alvaro López-Janeiro, Angelo Porciuncula, Miguel A Idoate, Susana Inogés, Carlos de Andrea, Ascensión López-Diaz de Cerio, Sonia Tejada,[...]. Nat Med 2019
217
50

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Timothy F Cloughesy, Aaron Y Mochizuki, Joey R Orpilla, Willy Hugo, Alexander H Lee, Tom B Davidson, Anthony C Wang, Benjamin M Ellingson, Julie A Rytlewski, Catherine M Sanders,[...]. Nat Med 2019
395
50

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity.
Kaori Sakuishi, Lionel Apetoh, Jenna M Sullivan, Bruce R Blazar, Vijay K Kuchroo, Ana C Anderson. J Exp Med 2010
50

When worlds collide: Th17 and Treg cells in cancer and autoimmunity.
Hannah M Knochelmann, Connor J Dwyer, Stefanie R Bailey, Sierra M Amaya, Dirk M Elston, Joni M Mazza-McCrann, Chrystal M Paulos. Cell Mol Immunol 2018
124
50


Angiogenesis in brain tumours.
Rakesh K Jain, Emmanuelle di Tomaso, Dan G Duda, Jay S Loeffler, A Gregory Sorensen, Tracy T Batchelor. Nat Rev Neurosci 2007
903
50

Anti-CD20 monoclonal antibodies: reviewing a revolution.
J M L Casan, J Wong, M J Northcott, S Opat. Hum Vaccin Immunother 2018
26
50

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.
Filipe Martins, Latifyan Sofiya, Gerasimos P Sykiotis, Faiza Lamine, Michel Maillard, Montserrat Fraga, Keyvan Shabafrouz, Camillo Ribi, Anne Cairoli, Yan Guex-Crosier,[...]. Nat Rev Clin Oncol 2019
413
50



Th17 cells in autoimmune and infectious diseases.
José Francisco Zambrano-Zaragoza, Enrique Jhonatan Romo-Martínez, Ma de Jesús Durán-Avelar, Noemí García-Magallanes, Norberto Vibanco-Pérez. Int J Inflam 2014
84
50

Role of LAG-3 in regulatory T cells.
Ching-Tai Huang, Creg J Workman, Dallas Flies, Xiaoyu Pan, Aimee L Marson, Gang Zhou, Edward L Hipkiss, Sowmya Ravi, Jeanne Kowalski, Hyam I Levitsky,[...]. Immunity 2004
742
50

Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells.
Hidenori Takahashi, Muneo Numasaki, Michael T Lotze, Hidetada Sasaki. Immunol Lett 2005
108
50

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.
Laurent Monney, Catherine A Sabatos, Jason L Gaglia, Akemi Ryu, Hanspeter Waldner, Tatyana Chernova, Stephen Manning, Edward A Greenfield, Anthony J Coyle, Raymond A Sobel,[...]. Nature 2002
50

CTLA-4 correlates with immune and clinical characteristics of glioma.
Fangkun Liu, Jing Huang, Xuming Liu, Quan Cheng, Chengke Luo, Zhixiong Liu. Cancer Cell Int 2020
24
50

Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus.
Ana Henriques, Luís Inês, Maura Couto, Susana Pedreiro, Catarina Santos, Mariana Magalhães, Paulo Santos, Isabel Velada, Anabela Almeida, Tiago Carvalheiro,[...]. Cell Immunol 2010
68
50

LAG-3, a novel lymphocyte activation gene closely related to CD4.
F Triebel, S Jitsukawa, E Baixeras, S Roman-Roman, C Genevee, E Viegas-Pequignot, T Hercend. J Exp Med 1990
427
50

Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.
Yi Chen, Claire L Langrish, Brent McKenzie, Barbara Joyce-Shaikh, Jason S Stumhofer, Terrill McClanahan, Wendy Blumenschein, Tatyana Churakovsa, Justin Low, Leonard Presta,[...]. J Clin Invest 2006
450
50

Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition.
Aida Karachi, Changlin Yang, Farhad Dastmalchi, Elias J Sayour, Jianping Huang, Hassan Azari, Yu Long, Catherine Flores, Duane A Mitchell, Maryam Rahman. Neuro Oncol 2019
33
50

Transforming growth factor-beta : biology and clinical relevance.
Isaac Yi Kim, Moses M Kim, Seong-Jin Kim. J Biochem Mol Biol 2005
71
50

Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.
Giovanni Monteleone, Markus F Neurath, Sandro Ardizzone, Antonio Di Sabatino, Massimo C Fantini, Fabiana Castiglione, Maria L Scribano, Alessandro Armuzzi, Flavio Caprioli, Giacomo C Sturniolo,[...]. N Engl J Med 2015
272
50

CD155/PVR plays a key role in cell motility during tumor cell invasion and migration.
Kevin E Sloan, Brenda K Eustace, Jean K Stewart, Carol Zehetmeier, Claudia Torella, Marina Simeone, Jennifer E Roy, Christine Unger, David N Louis, Leodevico L Ilag,[...]. BMC Cancer 2004
157
50

TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy.
William C Dougall, Sema Kurtulus, Mark J Smyth, Ana C Anderson. Immunol Rev 2017
209
50

Targeting the transforming growth factor-beta signaling pathway in human cancer.
Nagathihalli S Nagaraj, Pran K Datta. Expert Opin Investig Drugs 2010
181
50

Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells.
Malgorzata Kisielow, Jan Kisielow, Giuseppina Capoferri-Sollami, Klaus Karjalainen. Eur J Immunol 2005
131
50


Constitutive activation of casein kinase 2 in glioblastomas: Absence of class restriction and broad therapeutic potential.
Nadege Dubois, Marie Willems, Minh-Tuan Nguyen-Khac, Jerome Kroonen, Nicolas Goffart, Manuel Deprez, Vincent Bours, Pierre A Robe. Int J Oncol 2016
9
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.